(Q40869292)

24 September 2017

1 reference

title

Mechanisms of drug resistance in ovarian cancer (English)

1 reference

24 September 2017

1 reference

Johnson SW

1

1 reference

24 September 2017

Ozols RF

series ordinal

2

1 reference

24 September 2017

Hamilton TC

series ordinal

3

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 January 1993

1 reference

24 September 2017

1 reference

24 September 2017

volume

71

1 reference

24 September 2017

issue

2 Suppl

1 reference

24 September 2017

page(s)

644-649

1 reference

Resistance to alkylating agents and cisplatin: insights from ovarian carcinoma model systems

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

Ovarian cancer, Part I: Biology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

Molecular mechanisms of drug resistance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

Resistance to cisplatin and analogues: mechanisms and potential clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

Multidrug resistance in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

Short-term cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

Modulation ofcis-diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine in sensitive and resistant human ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

Cross-linking of glutathione to DNA by cancer chemotherapeutic platinum coordination complexes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug resistance: intrinsic differences and cell cycle effects.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

Reduction in glutathione content of L-PAM resistant L1210 Cells confers drug sensitivity.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

Depletion of Glutathione in Normal and Malignant Human Cells In Vivo by Buthionine Sulfoximine: Clinical and Biochemical Results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

1 reference

7 January 2021

Overexpression of metallothionein confers resistance to anticancer drugs.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

Overexpression of metallothionein in CHO cells and its effect on cell killing by ionizing radiation and alkylating agents

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

Metallothionein gene expression and resistance to cisplatin in human ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

Metallothionein-mediated cisplatin resistance in human ovarian carcinoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

Metallothionein levels in ovarian tumours before and after chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

The quantitative detection of various Pt-DNA-adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniques

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

Enhanced DNA repair and resistance to cisplatin in human ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

Heterogeneity of DNA repair at the gene level

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

Lack of significant modulation of the formation and removal of platinum-DNA adducts by aphidicolin glycinate in two logarithmically-growing ovarian tumour cell lines in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

Inhibition of DNA repair and the enhancement of cytotoxicity of alkylating agents

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

Novobiocin enhances alkylating agent cytotoxicity and DNA interstrand crosslinks in a murine model

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

Properties and applications of human DNA repair genes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

Potential negative regulation of damage-recognition proteins in cisplatin-resistant HeLa cells in response to DNA damage

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

Cisplatin-resistant cells express increased levels of a factor that recognizes damaged DNA.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710224

7 January 2021

Identifiers

DOI

10.1002/CNCR.2820710224

0 references

1 reference